Susan is an experienced biotech executive and entrepreneur, holding the title of CEO at Propel Biosciences, and providing consulting in the form of strategy, business development, fractional leadership and marketing in cell and gene therapy drug development, tools, technologies and services. Susan is very involved in the cell and gene therapy community, is passionate about patient advocacy and is a champion of diversity initiatives.